The Cardiolipin Antibody (ACL-IgA) test measures the presence of IgA-type antibodies directed against cardiolipin, a phospholipid found in cell membranes. Elevated levels of these antibodies may indicate an increased risk of autoimmune disorders, particularly antiphospholipid syndrome (APS), which can lead to abnormal blood clotting, recurrent miscarriages, or vascular complications. This test is often performed alongside ACL-IgG and ACL-IgM antibodies to provide a comprehensive assessment of autoimmune-related coagulation risks. Results help clinicians diagnose, monitor, and manage patients with suspected autoimmune or thrombotic disorders.

• Reports On : With 24 Hours
• Sample Type : Blood
• Fasting : Not Required